Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels

Chemoresistance is a major problem in the therapeutic management of pancreatic cancer, concurring to poor clinical outcome. A number of mechanisms have been proposed to explain resistance to gemcitabine, a standard of care for this malignancy, among which is included aberrant miRNA expression. In th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomolecules
Main Authors: Panebianco, Concetta, Trivieri, Nadia, Villani, Annacandida, Terracciano, Fulvia, Latiano, Tiziana Pia, Potenza, Adele, Perri, Francesco, Binda, Elena, Pazienza, Valerio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146031/
https://ncbi.nlm.nih.gov/pubmed/33925948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11050639
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados